| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/17/1996 | EP0692535A1 Oligonucleotides to inhibit the role of isoprenyl protein transferases |
| 01/17/1996 | EP0692457A2 A hexagonal molecular structure water manufacturing apparatus and a method thereof |
| 01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 01/17/1996 | EP0691988A1 Inhibitor of stem cell proliferation and uses thereof |
| 01/17/1996 | EP0691979A1 Novel 5'-substituted nucleosides and oligomers produced therefrom |
| 01/17/1996 | EP0691977A1 Oligonucleotides with amide linkages replacing phosphodiester linkages |
| 01/17/1996 | EP0691964A1 (3-ketotetrahydrofuran-2-yl)ethanal derivatives and a method for their preparation |
| 01/17/1996 | EP0691962A1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance |
| 01/17/1996 | EP0691854A1 Conjugates of proteins and bifunctional ligands |
| 01/17/1996 | EP0691853A1 ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION |
| 01/17/1996 | EP0515544B1 Steroid sulphatase inhibitors |
| 01/17/1996 | EP0493480B1 Dehydrodidemnin b |
| 01/17/1996 | EP0436526B1 Use of antibodies to angiogenin: immunotherapeutic agents |
| 01/17/1996 | CN1115181A Process for the preparation of 9-amino camptothecin |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1030718C Superoxide dismutase |
| 01/17/1996 | CN1030703C Neurokinin A antagonists |
| 01/17/1996 | CN1030702C 芪衍生物 Stilbene derivatives |
| 01/16/1996 | US5484951 Treatment of aids, herpes, cytomegalo virus, antitumor agents |
| 01/16/1996 | US5484935 Pharmaceutical compounds |
| 01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
| 01/16/1996 | US5484889 Plant protein useful for treating tumors and HIV infection |
| 01/16/1996 | US5484809 Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid |
| 01/16/1996 | US5484803 Transcutaneous in vivo activation of photosensitive agents in blood |
| 01/16/1996 | US5484798 Benzothiopene compounds, compositions, and method of inhibiting restenosis |
| 01/16/1996 | US5484797 Naphthly compounds, intermediates, processes, compositions, and method for inhibiting endometrosis |
| 01/16/1996 | US5484796 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting aortal smooth muscle cell proliferation |
| 01/16/1996 | US5484795 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting restenosis |
| 01/16/1996 | US5484778 Anticarcinogenic agents or antitumor agents |
| 01/16/1996 | US5484770 Peptide compounds which inhibit the proliferation of epidermal or epithelial stem cells |
| 01/16/1996 | US5484715 Method for preparing an antitumor dextran using a dextran synthetase from Lactobacillus confusus |
| 01/16/1996 | US5484712 Method for producing aclacinomycins A, B, Y using Strepomyces lavendofoliae DKRS |
| 01/16/1996 | US5484704 Screening tissues for cancer cells |
| 01/16/1996 | US5484612 Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin |
| 01/16/1996 | US5484584 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 01/16/1996 | CA1337937C Tricyclic 3-oxo-propanenitrile derivatives and process for their preparation |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | WO1996000736A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 01/11/1996 | WO1996000732A1 Phosphinic acid derivatives |
| 01/11/1996 | WO1996000730A1 Vitronectin receptor antagonists |
| 01/11/1996 | WO1996000726A2 New brefeldin a derivatives and their utility in the treatment of cancer |
| 01/11/1996 | WO1996000724A1 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 01/11/1996 | WO1996000579A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria |
| 01/11/1996 | WO1996000574A1 Vitronectin receptor antagonists |
| 01/11/1996 | WO1996000572A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 01/11/1996 | WO1996000568A1 Anti-metastatic agent |
| 01/11/1996 | WO1996000503A1 Novel peptides |
| 01/11/1996 | DE4425857A1 Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 01/11/1996 | DE4423392A1 Verfahren zur Identifizierung antigener Peptide A method for identifying antigenic peptides |
| 01/11/1996 | DE4422859A1 Wäßrige Zellextrakte und wäßrige Suspensionen von Zellwandfraktionen aus Mykobacterien Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteriae |
| 01/11/1996 | DE4422259A1 Anti-Sinn-Oligonukleotide zur Aromatase-Inhibierung Antisense oligonucleotides for aromatase inhibition |
| 01/11/1996 | DE4418690A1 Nucleoside 5'-mono-phosphate ester(s) of glyceryl di:ether derivs. |
| 01/11/1996 | CA2194138A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria |
| 01/11/1996 | CA2193966A1 Vitronectin receptor antagonists |
| 01/11/1996 | CA2193704A1 New brefeldin a derivatives and their utility in the treatment of cancer |
| 01/11/1996 | CA2192957A1 Semenogelin-derived oligopeptides cleavable by prostate specific antigen |
| 01/11/1996 | CA2191605A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 01/11/1996 | CA2191224A1 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 01/11/1996 | CA2190977A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 01/11/1996 | CA2190756A1 Endothelin antagonists ii |
| 01/10/1996 | EP0691350A2 uPA binding sites on domain 2+3 on uPAR and antibodies reactive therewith |
| 01/10/1996 | EP0690915A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690871A1 Growth differentiation factor-5 |
| 01/10/1996 | EP0690867A1 Taxanes having furyl or thienyl substituted side-chain |
| 01/10/1996 | EP0690856A1 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment |
| 01/10/1996 | EP0690852A1 Method for purifying taxoids |
| 01/10/1996 | EP0690841A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 01/10/1996 | EP0690840A1 Novel distamycin analogues |
| 01/10/1996 | EP0690722A1 Composition and method for reducing toxicity of biologically-active factors |
| 01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 01/10/1996 | EP0690717A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 01/10/1996 | EP0690716A1 OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH |
| 01/10/1996 | EP0690714A1 3-(7-oxo-1-aza-4-oxabicyclo 3.2.0]hept-3-yl) alanine derivative as antitumor agent |
| 01/10/1996 | EP0690712A1 Taxanes having a pyridyl substituted side-chain |
| 01/10/1996 | EP0690711A1 Taxanes having an amino substituted side-chain |
| 01/10/1996 | EP0394429B1 Preparation for transdermal application containing gestodene |
| 01/10/1996 | CN1114650A MDR reversal agents |
| 01/10/1996 | CN1030658C Octadecyl (2-(N-methyl-priperidino)-ethyl)-phosphate and process for its preparation |
| 01/09/1996 | US5482963 Pharmaceutical agents useful as leukotriene antagonists |
| 01/09/1996 | US5482954 Antitumor agents, interruption of signalling mechanism required for survival of malignant cells |
| 01/09/1996 | US5482949 Inhibiting bone loss, lowering cholesterol levels, and treating estrogen dependent mammary or uterine carcinoma |
| 01/09/1996 | US5482948 Pyridyl derivatives and pharmaceutical compositions comprising these compounds |
| 01/09/1996 | US5482945 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 01/09/1996 | US5482853 Nuclear sequence for cellular genomes |
| 01/09/1996 | US5482711 Use of Nigella sativa to increase immune function |
| 01/09/1996 | CA2153208A1 Upa binding sites on domain 2+3 on upar and antibodies reactive therewith |
| 01/09/1996 | CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use |
| 01/04/1996 | WO1996000232A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF |
| 01/04/1996 | WO1996000231A1 Anti-sense oligonucleotides for aromatase inhibition |
| 01/04/1996 | WO1996000229A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 01/04/1996 | WO1996000226A1 Substituted azaindolylidene compounds and process for their preparation |
| 01/04/1996 | WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/04/1996 | WO1996000205A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 01/04/1996 | WO1996000084A1 Use of autoantibodies for tumor therapy and prophylaxis |
| 01/04/1996 | WO1996000082A1 Medical use of bromelain |
| 01/04/1996 | WO1996000007A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 01/04/1996 | WO1995029193A3 Melanoma antigens |
| 01/04/1996 | CA2193654A1 Medical use of bromelain |
| 01/04/1996 | CA2193373A1 Ribozymes with optimized hybridizing arms, stems, and loops, trna embedded ribozymes and compositions thereof |